Jiuliang Zhao,Xinping Tian,Mengtao Li et al.
Jiuliang Zhao et al.
Reevaluating risk assessment in connective tissue disease-associated pulmonary arterial hypertension: The prognostic superiority of stroke volume index [0.03%]
从连接性心血管疾病相关肺动脉高压重新评估风险评估：脑血体积指数的预后优势
Qingqing Cai,Huangshu Ye,Yixin Zhang et al.
Qingqing Cai et al.
Objective: To evaluate the prognostic value of stroke volume index (SVI) compared to cardiac index (CI) in risk stratification and outcome prediction in connective tissue disease-associated pulmonary arterial hypertension...
Shaoyu Zheng,Guangzhou Du,Yukai Wang
Shaoyu Zheng
Association of ficolin single nucleotide polymorphism with systemic lupus erythematosus in the Chinese Han Population [0.03%]
汉族人群溶血卵磷脂酶多态性与系统性红斑狼疮的关联研究
Feng Yin,Jinhua Gu,Ping Zhao et al.
Feng Yin et al.
2025 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus [0.03%]
2025年中国系统性红斑狼疮诊断和治疗指南
Jiuliang Zhao,Shangzhu Zhang,Qian Wang et al.
Jiuliang Zhao et al.
Systemic lupus erythematosus (SLE) is a complex autoimmune disease that poses significant challenges in diagnosis and treatment. In recent years, advances in basic and clinical research related to SLE have led to the emergence of new diagno...
Association of HLA-B and HLA-DR gene polymorphisms with rheumatoid arthritis: A cross-sectional study in Yunnan Chinese Han population [0.03%]
汉族人群风湿性关节炎与HLA-B和HLA-DR基因多态性的关联：云南汉族人群的横断面研究
Jing Dong,Yifan Yang,Minghuang Mo et al.
Jing Dong et al.
Objectives: To investigate the association between HLA-B and HLA-DR gene polymorphisms and rheumatoid arthritis (RA) in Yunnan Han population, China. Meth...
The emerging role of cardiovascular magnetic resonance in the evaluation of cardiac involvement in systemic sclerosis [0.03%]
心血管磁共振在评估系统性硬化症心脏受累中的作用不容忽视
Sophie I Mavrogeni,Alessia Pepe
Sophie I Mavrogeni
Systemic sclerosis (SSc) is an autoimmune rheumatic disease, characterized by vascular, inflammatory and fibrotic alterations. Cardiac involvement is the « fatal tip of the iceberg» in SSc, as it leads to high morbidity/mortality. Cardiov...
Rituximab in the treatment of anti-HMGCR immune-mediated necrotizing myopathy: Two cases successfully treated [0.03%]
利妥昔单抗治疗抗HMGCR免疫介导的坏死性肌病：两例成功治疗的病例报告
Giulia Micheli,Lorenzo Salvati,Boaz Palterer et al.
Giulia Micheli et al.
Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: Results from a real-world CSTAR cohort study [0.03%]
他莫昔芬与来曲唑治疗中国绝经前激素受体阳性乳腺癌的非劣性 randomized phase 3 tedinya study
Wei Bai,Liying Peng,Yinli Gui et al.
Wei Bai et al.
Background and objectives: No prior studies have directly compared sirolimus with the standard of care (SoC) for lupus nephritis (LN) patients. This study aimed to compare the efficacy and safety of sirolimus with mycophe...
Predicting response to infliximab and interferon-α in Behçet's syndrome: An exploratory analysis from the BIO-BEHÇET'S randomized controlled trial [0.03%]
贝赫切特综合征对英夫利昔和干扰素治疗反应的预测：来自BIO-BEHçET随机对照试验的探索性分析
Robert J Moots,Farida Fortune,Richard Jackson et al.
Robert J Moots et al.
Background and objectives: Biologic therapy has been used for Behçet's Syndrome after first-line immunomodulation, but in the absence of high-quality evidence or predictive biomarkers. BIO-BEHÇET'S was a randomized cont...